Sysmex America, Inc. Risk Report

📜 Innovation & R&D

Sysmex America, Inc. continues to prioritize its commitment to technological advancement and healthcare innovation. The company received significant recognition for its development and launching of several products and technologies. These advancements position Sysmex at the forefront of its industry, reflecting its dedication to enhancing diagnostic precision and broadening its market reach.

• Sysmex America received FDA clearance for the automated blood coagulation analyzer CN-Series CN-6000™ on 🗓 June 25, 2025.
• Sysmex America expanded its line of 3-part differential automated hematology analyzers with the introduction of the XQ-320 on 🗓 March 3, 2025.
• Sysmex developed the world’s first blood testing system, highlighting its innovative approach in healthcare, reported on 🗓 April 10, 2025.
• Sysmex America collaborated with Yaskawa for the Autosorter XN, enhancing pre- and post-analytic specimen processing in its XN-Series, announced on 🗓 April 1, 2025.